BPC-157 Research Peptide

BPC-157 is a synthetic 15-amino-acid peptide also described as a gastric pentadecapeptide.

• BPC-157, BPC157, and BPC 157 are spelling variants; “body protection compound” is a name, not proof of a protective effect.
• Sequence confirmation and mass analysis are needed to identify a research sample.

Research has examined gastrointestinal protection, angiogenesis, nitric-oxide-related signaling, inflammation, and tissue-repair models.

• Muscle, tendon, ligament, nerve, and gastrointestinal findings come predominantly from animal or laboratory studies.
• Proposed mechanisms remain incompletely defined, and an effect in one injury model cannot be generalized to people or other tissues.
• This category covers sequence, preclinical pathways, stability, testing, comparisons, and research limitations.

Systematic reviews find extensive preclinical literature but very limited and weakly controlled human data.

• No standardized pharmaceutical formulation or validated general clinical regimen has been established.
• BPC-157 is not an FDA-approved medicine, and unregulated material adds unresolved identity, contamination, and sterility risks.